Literature DB >> 27179578

Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS.

Monika Szafarowska1, Agnieszka Segiet2, Malgorzata M Jerzak1.   

Abstract

OBJECTIVES: The aim of this study was to compare SNP C677T and A1298C in the MTHFR gene and pregnancy outcome in PCOS women. STUDY
DESIGN: We investigated 76 PCOS and 56 non-PCOS women. Among PCOS patients 63 were women with a history of recurrent pregnancy loss (RPL) and 13 women were infertile. In non-PCOS group 40 women were RPL and 16 were infertile. We investigated the relationship between SNP in the MTHFR gene and pregnancy loss, homocysteine and AMH concentration in the study groups.
RESULTS: DNA analysis of the PCOS and non-PCOS groups for MTHFR C677T and A1298C polymorphism showed no significant association between the groups. We demonstrated an increased miscarriage rate in non-PCOS women with A1298C polymorphism in the MTHFR gene (p=0.042). We found that homocysteine concentration was higher in women with SNP MTHFR A1298C (p=0.046). Moreover, we did not observe any association between the level of homocysteine and the pregnancy outcome in the whole study group. CONSLUSION: It seems that the presence of the MTHFR mutation is not associated with PCOS in the Polish population. However, our results may suggest a correlation between the MTHFR A1298C mutation and RPL in the non-PCOS group.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27179578

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

Review 1.  Potential genetic polymorphisms predicting polycystic ovary syndrome.

Authors:  Yao Chen; Shu-Ying Fang
Journal:  Endocr Connect       Date:  2018-04-05       Impact factor: 3.335

2.  Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies.

Authors:  Lihong Wang; Wenting Xu; Caihong Wang; Mengyu Tang; Yujia Zhou
Journal:  Oncotarget       Date:  2017-06-14

3.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

4.  Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update.

Authors:  Yin Li; Hongqiu Zhu; Min Liu; Zhulan Zeng; Yanling Zeng; Xinlei Xu; Min Ye
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

5.  Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women.

Authors:  Wanqin Feng; Yan Zhang; Yuan Pan; Yi Zhang; Minjuan Liu; Yuxin Huang; Yuanling Xiao; Wenyu Mo; Junjie Jiao; Xiaoyang Wang; Dan Tian; Lixia Yang; Ying Ma
Journal:  Reprod Biol Endocrinol       Date:  2021-01-07       Impact factor: 5.211

Review 6.  Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence.

Authors:  Régine P M Steegers-Theunissen; Rosalieke E Wiegel; Pauline W Jansen; Joop S E Laven; Kevin D Sinclair
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.